Development, Characterization & Comparative Evaluation of Nanostructured Lipid Carriers and Solid Lipid Nanoparticles for Potent Oral Delivery of Furosemide
Journal Title: Saudi Journal of Medical and Pharmaceutical Sciences - Year 2018, Vol 4, Issue 11
Abstract
The aim of the present study was to increase the solubility and thereby improve the oral bioavailability of Furosemide by incorporating the drug in nanostructured lipid carriers (NLC) and in solid lipid nanoparticle (SLN) and also to compare the efficiency of NLC over SLN. Both the NLC and SLN were prepared by solvent diffusion method using labrafil m 2130 as solid lipid, capryol pgmc as liquid lipid, and tween 80 as surfactant. Properties of Furosemide loaded NLCs & SLNs such as drug content, entrapment efficiency, loading capacity, particle size, PDI , zeta potential, morphology, storage stability, in vitro drug release and mechanism of drug release were investigated and compared. Drug content, entrapment efficiency, loading capacity, average particle size, PDI and zeta potential of Furosemide NLC were found to 83.56%, 75.50%, 25.63%, 99.24nm, 0.302 and -31.2mV and that of Furosemide SLN were found to 84.55%, 71.07%, 24.62%, 193.4nm, 0.835 and -36.1mV respectively. Morphology study by scanning electron microscopy (SEM) analysis showed spherical particles with smooth surfaces. As compared to in-vitro drug release of Furosemide pure drug, both the NLC and SLN showed fast initial release followed by a sustained release, best fitted to Higuchi equation. Pure drug followed Zero order release kinetics. Furosemide NLC showed higher entrapment efficiency, drug loading capacity, in-vitro drug release, reduced the drug expulsion in storage when compared to SLN. This investigation demonstrated the efficiency of NLC over SLN for improved oral bioavailability of Furosemide and it was deduced that the liquid lipid (capryol pgmc)was the principal formulation factor responsible for the improvement in characteristics and pharmacokinetics of NLCs.
Authors and Affiliations
Anurughma S, Mrs. Neema George
Keywords
Related Articles
- EP ID EP488027
- DOI -
- Views 145
- Downloads 0
Primary and Secondary Malignant Cardiac Tumors Overview
Cardiac tumors are massively uncommon disease, only seven instances of primary cardiac tumor found between more than 12,000 dissections. Cardiac tumors are proliferated in the heart or heart valves. Cardiac tumors may...
Analysis of Matrix Metalloproteinases 13(MMP-13) non-synonymous Single Nucleotide Variants (nsSNVs) in Osteoarthritis and Prediction of Druggable Binding Sites Using COSMIC
Abstract:Osteoarthritis (OA) is a degenerative joint disease characterized by progressive loss and damage of articular cartilage. Increased collagenase activity has a direct impact in the cleavage of type II collagen in...
Role of Solid Lipid Nanoparticles in Oral Bioavailability Enhancement of Antihypertensive Drugs
Abstract:Solid lipid nanoparticles (SLNs) are at the rapidly developed field of nanotechnology with a few potential applications in drug delivery, clinical medication and research, and additionally in other distorted sci...
Optimal Treatment of the Septic Pseudarthrosis of the Tibial Pestle: About A Case
The deleterious association of non-bone consolidation and septic complication is a therapeutic challenge for orthopedic surgeons. Tibial fractures are a source of high rates of nonunion and septic and cutaneous complicat...
Biowaiver studies of seven generic brands of allopurinol (100 mg) tablets available in Sudanese market
Abstract:Allopurinol is the drug of choice in the treatment of gout It reduces the concentration of urates and uric acid in tissues, plasma and urine, while increasing the concentration of xanthine and hypoxanthine.The p...